Loading company
OKYO Pharma Ltd (OKYO) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Net income | -$4.7 million | -$16.8 million | 20-F 2025-07-18 · proof | |
| Cash from operating activities | -$1.8 million | -$9.5 million | 20-F 2025-07-18 · proof | |
| Free cash flow | -$1.8 million | 20-F 2025-07-18 · proof | ||
| Total assets | $3.7 million | $1.5 million | +138.6% | 20-F 2025-07-18 · proof |
| Total liabilities | $9.2 million | $7.4 million | +24.3% | 20-F 2025-07-18 · proof |
| Cash and cash equivalents | $1.6 million | $826,848 | +88.8% | 20-F 2025-07-18 · proof |
- What was OKYO Pharma Ltd (OKYO)'s net income in fiscal 2025?
- OKYO Pharma Ltd (OKYO) reported net income of -$4.7 million for fiscal 2025 (the year ended Mar 31, 2025), against -$16.8 million the year before. Source: the 20-F filed with the SEC on Jul 18, 2025. SEC
- What was OKYO Pharma Ltd (OKYO)'s cash from operating activities in fiscal 2025?
- OKYO Pharma Ltd (OKYO) reported cash from operating activities of -$1.8 million for fiscal 2025 (the year ended Mar 31, 2025), against -$9.5 million the year before. Source: the 20-F filed with the SEC on Jul 18, 2025. SEC
- What was OKYO Pharma Ltd (OKYO)'s free cash flow in fiscal 2025?
- OKYO Pharma Ltd (OKYO) reported free cash flow of -$1.8 million for fiscal 2025 (the year ended Mar 31, 2025). Source: the 20-F filed with the SEC on Jul 18, 2025. SEC
- What are OKYO Pharma Ltd (OKYO)'s total assets?
- As of Mar 31, 2025, OKYO Pharma Ltd (OKYO) reported total assets of $3.7 million, against $1.5 million a year earlier (+138.6%). Source: the 20-F filed with the SEC on Jul 18, 2025. SEC
- What are OKYO Pharma Ltd (OKYO)'s total liabilities?
- As of Mar 31, 2025, OKYO Pharma Ltd (OKYO) reported total liabilities of $9.2 million, against $7.4 million a year earlier (+24.3%). Source: the 20-F filed with the SEC on Jul 18, 2025. SEC
- What are OKYO Pharma Ltd (OKYO)'s cash and cash equivalents?
- As of Mar 31, 2025, OKYO Pharma Ltd (OKYO) reported cash and cash equivalents of $1.6 million, against $826,848 a year earlier (+88.8%). Source: the 20-F filed with the SEC on Jul 18, 2025. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:OKYO&period_type=annual&limit=5"Information only, not investment advice.